Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | MSH6 |
Variant | K1014del |
Impact List | deletion |
Protein Effect | unknown |
Gene Variant Descriptions | MSH6 K1014del results in the deletion of an amino acid in the lever domain of the Msh6 protein at amino acid 1014 (PMID: 17531815). K1014del has been identified in the scientific literature (PMID: 29875428, PMID: 36260514), but has not been biochemically characterized and therefore, its effect on Msh6 protein function is unknown (PubMed, Apr 2024). |
Associated Drug Resistance | |
Category Variants Paths |
MSH6 mutant MSH6 K1014del |
Transcript | NM_000179.3 |
gDNA | chr2:g.47801023_47801025delAAG |
cDNA | c.3040_3042delAAG |
Protein | p.K1014delK |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001406802.1 | chr2:g.47800927_47800929delCCT | c.3040_3042delCCT | p.P1014delP | RefSeq | GRCh38/hg38 |
NM_001406830.1 | chr2:g.47803584_47803586delATT | c.3040_3042delATT | p.I1014delI | RefSeq | GRCh38/hg38 |
NM_001406823.1 | chr2:g.47806596_47806598delGGA | c.3040_3042delGGA | p.G1014delG | RefSeq | GRCh38/hg38 |
NM_001406803.1 | chr2:g.47806557_47806559delGCA | c.3043_3045delGCA | p.A1015delA | RefSeq | GRCh38/hg38 |
NM_001281493.2 | chr2:g.47806596_47806598delGGA | c.3040_3042delGGA | p.G1014delG | RefSeq | GRCh38/hg38 |
XM_024452819.1 | chr2:g.47801023_47801025delAAG | c.3040_3042delAAG | p.K1014del | RefSeq | GRCh38/hg38 |
NM_001406811.1 | chr2:g.47806596_47806598delGGA | c.3040_3042delGGA | p.G1014delG | RefSeq | GRCh38/hg38 |
NM_001406804.1 | chr2:g.47801101_47801103delTTT | c.3040_3042delTTT | p.F1014delF | RefSeq | GRCh38/hg38 |
NM_001406815.1 | chr2:g.47806596_47806598delGGA | c.3040_3042delGGA | p.G1014delG | RefSeq | GRCh38/hg38 |
NM_001406816.1 | chr2:g.47806596_47806598delGGA | c.3040_3042delGGA | p.G1014delG | RefSeq | GRCh38/hg38 |
NM_001406813.1 | chr2:g.47801017_47801019delGAA | c.3040_3042delGAA | p.E1014delE | RefSeq | GRCh38/hg38 |
NM_001406797.1 | chr2:g.47803584_47803586delATT | c.3040_3042delATT | p.I1014delI | RefSeq | GRCh38/hg38 |
NM_001406819.1 | chr2:g.47803584_47803586delATT | c.3040_3042delATT | p.I1014delI | RefSeq | GRCh38/hg38 |
NM_001406828.1 | chr2:g.47803584_47803586delATT | c.3040_3042delATT | p.I1014delI | RefSeq | GRCh38/hg38 |
NM_001406824.1 | chr2:g.47803584_47803586delATT | c.3040_3042delATT | p.I1014delI | RefSeq | GRCh38/hg38 |
NM_001281494.2 | chr2:g.47806596_47806598delGGA | c.3040_3042delGGA | p.G1014delG | RefSeq | GRCh38/hg38 |
NM_001406812.1 | chr2:g.47806596_47806598delGGA | c.3040_3042delGGA | p.G1014delG | RefSeq | GRCh38/hg38 |
NM_000179.2 | chr2:g.47801023_47801025delAAG | c.3040_3042delAAG | p.K1014del | RefSeq | GRCh38/hg38 |
NM_001406796.1 | chr2:g.47801023_47801025delAAG | c.3040_3042delAAG | p.K1014delK | RefSeq | GRCh38/hg38 |
NM_001406814.1 | chr2:g.47806596_47806598delGGA | c.3040_3042delGGA | p.G1014delG | RefSeq | GRCh38/hg38 |
NM_001406798.1 | chr2:g.47801023_47801025delAAG | c.3040_3042delAAG | p.K1014delK | RefSeq | GRCh38/hg38 |
NM_001406826.1 | chr2:g.47803456_47803458delGTG | c.3041_3043delGTG | p.G1014delG | RefSeq | GRCh38/hg38 |
NM_001406809.1 | chr2:g.47801023_47801025delAAG | c.3040_3042delAAG | p.K1014delK | RefSeq | GRCh38/hg38 |
NM_001406829.1 | chr2:g.47806596_47806598delGGA | c.3040_3042delGGA | p.G1014delG | RefSeq | GRCh38/hg38 |
NM_001406799.1 | chr2:g.47805626_47805628delACA | c.3040_3042delACA | p.T1014delT | RefSeq | GRCh38/hg38 |
NM_001406807.1 | chr2:g.47805626_47805628delACA | c.3040_3042delACA | p.T1014delT | RefSeq | GRCh38/hg38 |
NM_001406808.1 | chr2:g.47801023_47801025delAAG | c.3040_3042delAAG | p.K1014delK | RefSeq | GRCh38/hg38 |
NM_001406806.1 | chr2:g.47805626_47805628delACA | c.3040_3042delACA | p.T1014delT | RefSeq | GRCh38/hg38 |
NM_000179.3 | chr2:g.47801023_47801025delAAG | c.3040_3042delAAG | p.K1014delK | RefSeq | GRCh38/hg38 |
NM_001406820.1 | chr2:g.47803584_47803586delATT | c.3040_3042delATT | p.I1014delI | RefSeq | GRCh38/hg38 |
NM_001406800.1 | chr2:g.47801023_47801025delAAG | c.3040_3042delAAG | p.K1014delK | RefSeq | GRCh38/hg38 |
NM_001281492.2 | chr2:g.47803678_47803680delTGA | c.3041_3043delTGA | p.M1014delM | RefSeq | GRCh38/hg38 |
NM_001406801.1 | chr2:g.47803584_47803586delATT | c.3040_3042delATT | p.I1014delI | RefSeq | GRCh38/hg38 |
NM_001406827.1 | chr2:g.47803584_47803586delATT | c.3040_3042delATT | p.I1014delI | RefSeq | GRCh38/hg38 |
NM_001406818.1 | chr2:g.47803584_47803586delATT | c.3040_3042delATT | p.I1014delI | RefSeq | GRCh38/hg38 |
NM_001406822.1 | chr2:g.47803584_47803586delATT | c.3040_3042delATT | p.I1014delI | RefSeq | GRCh38/hg38 |
NM_001406805.1 | chr2:g.47803584_47803586delATT | c.3040_3042delATT | p.I1014delI | RefSeq | GRCh38/hg38 |
NM_001406795.1 | chr2:g.47800927_47800929delCCT | c.3040_3042delCCT | p.P1014delP | RefSeq | GRCh38/hg38 |
NM_001406825.1 | chr2:g.47803584_47803586delATT | c.3040_3042delATT | p.I1014delI | RefSeq | GRCh38/hg38 |
NM_001406821.1 | chr2:g.47803584_47803586delATT | c.3040_3042delATT | p.I1014delI | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
MSH6 mutant | rectum cancer | not applicable | N/A | Guideline | Risk Factor | Lynch syndrome results from germline mutations in DNA mismatch repair genes including MLH1, MSH2, MSH6, and PMS2, and is associated with increased risk of developing colorectal cancer (NCCN.org). | detail... |
MSH6 mutant | pancreatic cancer | not applicable | N/A | Guideline | Risk Factor | Germline mutations in MSH6 result in Lynch syndrome, which is associated with increased risk of developing pancreatic cancer (NCCN.org). | detail... |
MSH6 mutant | ovarian cancer | not applicable | N/A | Guideline | Risk Factor | Germline mutations in MSH6 result in Lynch syndrome, which is associated with increased risk of ovarian cancer (NCCN.org). | detail... |
MSH6 mutant | small intestine adenocarcinoma | not applicable | N/A | Guideline | Risk Factor | Lynch syndrome results from germline mutations in DNA mismatch repair genes including MLH1, MSH2, MSH6, and PMS2, and is associated with increased risk of developing small bowel adenocarcinoma (NCCN.org). | detail... |
MSH6 mutant | colon cancer | not applicable | N/A | Guideline | Risk Factor | Lynch syndrome results from germline mutations in DNA mismatch repair genes including MLH1, MSH2, MSH6, and PMS2, and is associated with increased risk of developing colon cancer (NCCN.org). | detail... |
MSH6 mutant | stomach cancer | not applicable | N/A | Guideline | Risk Factor | Germline mutations in MSH6 result in Lynch syndrome, which is associated with increased risk of developing pancreatic cancer (NCCN.org). | detail... |
MSH6 mutant | endometrial carcinoma | not applicable | N/A | Guideline | Risk Factor | Germline mutations in MSH6 result in Lynch syndrome, which is associated with increased risk of developing endometrial carcinoma (NCCN.org). | detail... |
MSH6 mutant | colorectal cancer | not applicable | N/A | Clinical Study | Diagnostic | Germline mutations in MSH6 are associated with microsatellite instability in colorectal cancer (CRC), and are diagnostic for Lynch syndrome (hereditary nonpolyposis colorectal cancer) in colorectal cancer patients (PMID: 26582061; PMID: 19125127). | 26582061 19125127 |